Steven Robert Alberts, MD

  • 14918 Citations
  • 52 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1987 2019

  • 14918 Citations
  • 52 Scopus h-Index
  • 200 Article
  • 3 Chapter
  • 3 Review article
  • 2 Letter
Article
27 Citations (Scopus)

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

The Adjuvant Colon Cancer Endpoints (ACCENT) Group & Sargent, D. J., Dec 1 2014, In : Journal of the National Cancer Institute. 106, 12, dju333.

Research output: Contribution to journalArticle

Colonic Neoplasms
Recurrence
Survival
Neoplasms
Phase III Clinical Trials
31 Citations (Scopus)

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Fuchs, C. S., Niedzwiecki, D., Mamon, H. J., Tepper, J. E., Ye, X., Swanson, R. S., Enzinger, P. C., Haller, D. G., Dragovich, T., Alberts, S. R., Bjarnason, G. A., Willett, C. G., Gunderson, L. L., Alberts, S. R., Venook, A. P., Ilson, D., O'Reilly, E., Ciombor, K., Berg, D. J., Meyerhardt, J. & 1 others, Mayer, R. J., Nov 10 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 32, p. 3671-3677 7 p.

Research output: Contribution to journalArticle

Adjuvant Chemoradiotherapy
Epirubicin
Leucovorin
Fluorouracil
Cisplatin
18 Citations (Scopus)

Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators

Bardia, A., Loprinzi, C. L., Grothey, A. F., Nelson, G., Alberts, S. R., Menon, S., Thome, S., Gill, S. & Sargent, D., Feb 2010, In : Seminars in Oncology. 37, 1, p. 39-46 8 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Fluorouracil
Colonic Neoplasms
Disease-Free Survival
Survival

Adjuvant therapy for colon cancer: A review of current approaches and future directions

Alberts, S. R. & Erlichman, C., 1996, In : Seminars in Colon and Rectal Surgery. 7, 1, p. 40-46 7 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Levamisole
Adjuvant Chemotherapy
Group Psychotherapy
Fluorouracil
9 Citations (Scopus)

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147

Phipps, A. I., Shi, Q. D., Limburg, P. J., Nelson, G. D., Sargent, D. J., Sinicrope, F. A., Chan, E., Gill, S., Goldberg, R. M., Kahlenberg, M., Nair, S., Shields, A. F., Newcomb, P. A. & Alberts, S. R., 2016, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Alcohol Drinking
Colonic Neoplasms
Wine
Disease-Free Survival
Neoplasms
8 Citations (Scopus)

Alternate dosing of cetuximab for patients with metastatic colorectal cancer

Hubbard, J. M. & Alberts, S. R., Mar 2013, In : Gastrointestinal Cancer Research. 6, 2, p. 47-55 9 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Epidermal Growth Factor Receptor
irinotecan
oxaliplatin
Appointments and Schedules
44 Citations (Scopus)

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66

Alberts, S. R., Roh, M. S., Mahoney, M. R., O'Connell, M. J., Nagorney, D. M., Wagman, L., Smyrk, T. C., Weiland, T. L., Lai, L. L., Schwarz, R. E., Molina, R., Dentchev, T. & Bolton, J. S., Feb 10 2010, In : Journal of Clinical Oncology. 28, 5, p. 853-858 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Hepatic Artery
Colorectal Neoplasms
Breast
Neoplasm Metastasis
30 Citations (Scopus)

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

for the Alliance for Clinical Trials in Oncology & Sargent, D. J., Dec 1 2015, In : Clinical Cancer Research. 21, 23, p. 5294-5304 11 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Tumor Biomarkers
Colon
Carcinoma
Neoplasms
26 Citations (Scopus)

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Wang, Y., Ding, X., Wang, S., Moser, C. D., Shaleh, H. M., Mohamed, E. A., Chaiteerakij, R., Allotey, L. K., Chen, G., Miyabe, K., McNulty, M. S., Ndzengue, A., Barr Fritcher, E. G., Knudson, R. A., Greipp, P. T., Clark, K. J., Torbenson, M., Kipp, B. R., Zhou, J., Barrett, M. & 4 others, Gustafson, M., Alberts, S. R., Borad, M. J. & Roberts, L. R., Sep 28 2016, In : Cancer Letters. 380, 1, p. 163-173 11 p.

Research output: Contribution to journalArticle

Receptor, Fibroblast Growth Factor, Type 2
Cholangiocarcinoma
Heterografts
Proteins
Neoplasms
14 Citations (Scopus)

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

Pilot, H. C., Adjei, A., Reid, J. M., Sloan, J. A., Atherton, P. J., Rubin, J., Alberts, S. R., Duncan, B. A., Denis, L., Schaaf, L. J., Yin, D., Sharma, A., McGovren, P., Miller, L. L. & Erlichman, C., Aug 2006, In : Cancer Chemotherapy and Pharmacology. 58, 2, p. 165-172 8 p.

Research output: Contribution to journalArticle

irinotecan
Pharmacokinetics
Powders
Capsules
Tumors
21 Citations (Scopus)

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A., Safgren, S. L., Lathia, C. D. & Alberts, S. R., Oct 2005, In : Anti-Cancer Drugs. 16, 9, p. 997-1002 6 p.

Research output: Contribution to journalArticle

Matrix Metalloproteinase 12
Carboplatin
Etoposide
Pharmacokinetics
Matrix Metalloproteinase Inhibitors
6 Citations (Scopus)

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

NSC 366140
Carboplatin
Area Under Curve
Neoplasms
DNA Adducts
35 Citations (Scopus)
Proteasome Inhibitors
Carboplatin
Paclitaxel
Appointments and Schedules
Neoplasms
63 Citations (Scopus)

A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (Bortezomib, Velcade), in patients with advanced cancer

Dy, G. K., Thomas, J. P., Wilding, G., Bruzek, L., Mandrekar, S. J., Erlichman, C., Alberti, D., Binger, K., Pitot, H. C., Alberts, S. R., Hanson, L. J., Marnocha, R., Tutsch, K., Kaufmann, S. H. & Adjei, A., May 1 2005, In : Clinical Cancer Research. 11, 9, p. 3410-3416 7 p.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Appointments and Schedules
Proteasome Endopeptidase Complex
Neoplasms
Fatigue
22 Citations (Scopus)

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

Dy, G. K., Suri, A., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Atherton, P. J., Hanson, L. J., Burch, P. A., Rubin, J., Erlichman, C. & Adjei, A., Jun 2005, In : Cancer Chemotherapy and Pharmacology. 55, 6, p. 522-530 9 p.

Research output: Contribution to journalArticle

gemcitabine
Pemetrexed
Pharmacokinetics
Tumors
Toxicity
1 Citation (Scopus)

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Halfdanarson, T. R., Foster, N. R., Kim, G. P., Meyers, J. P., Smyrk, T. C., McCullough, A. E., Ames, M. M., Jaffe, J. P. & Alberts, S. R., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Epidermal Growth Factor Receptor
Neoplasms
Survival
14 Citations (Scopus)

A phase II study of topical ceramides for cutaneous breast cancer

Jatoi, A., Suman, V. J., Schaefer, P., Block, M., Loprinzi, C. L., Roche, P., Garneau, S., Morton, R., Stella, P. J., Alberts, S. R., Pittelkow, M., Sloan, J. A. & Pagano, R., Jul 2003, In : Breast Cancer Research and Treatment. 80, 1, p. 99-104 6 p.

Research output: Contribution to journalArticle

Ceramides
Skin Neoplasms
Breast Neoplasms
Apoptosis
Skin
30 Citations (Scopus)

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

Jatoi, A., Tirona, M. T., Cha, S. S., Alberts, S. R., Rowland, K. M., Morton, R. F., Nair, S., Kardinal, C. G., Stella, P. J., Mailliard, J. A., Sargent, D. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 115-123 9 p.

Research output: Contribution to journalArticle

irinotecan
docetaxel
Esophagogastric Junction
Cardia
Stomach
11 Citations (Scopus)

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

Goldberg, R. M., Kaufmann, S. H., Atherton, P., Sloan, J. A., Adjei, A., Pitot, H. C., Alberts, S. R., Rubin, J., Miller, L. L. & Erlichman, C., Oct 1 2002, In : Annals of Oncology. 13, 10, p. 1674-1680 7 p.

Research output: Contribution to journalArticle

irinotecan
Leucovorin
Fluorouracil
Colorectal Neoplasms
Appointments and Schedules
45 Citations (Scopus)

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu

Peethambaram, P. P., Melisko, M. E., Rinn, K. J., Alberts, S. R., Provost, N. M., Jones, L. A., Sims, R. B., Lin, L. R. C., Frohlich, M. W. & Park, J. W., Sep 15 2009, In : Clinical Cancer Research. 15, 18, p. 5937-5944 8 p.

Research output: Contribution to journalArticle

Immunotherapy
Neoplasms
Active Immunotherapy
Antigens
Ovarian Neoplasms
74 Citations (Scopus)

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

Adjei, A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In : Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

Research output: Contribution to journalArticle

gemcitabine
Neoplasms
Pharmacokinetics
Ideal Body Weight
National Cancer Institute (U.S.)
47 Citations (Scopus)

A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

Adjei, A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In : Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

Research output: Contribution to journalArticle

gemcitabine
tipifarnib
Transferases
Cisplatin
Maximum Tolerated Dose
5 Citations (Scopus)

A pilot study assessing social support among cancer patients enrolled on clinical trials: A comparison of younger versus older adults

Novotny, P. J., Smith, D. J., Guse, L., Rummans, T. A., Hartmann, L., Alberts, S. R., Goldberg, R., Gregory, D., Johnson, M. & Sloan, J. A., 2010, In : Cancer Management and Research. 2, 1, p. 133-142 10 p.

Research output: Contribution to journalArticle

Social Support
Clinical Trials
Neoplasms
Phase III Clinical Trials
Sleep Initiation and Maintenance Disorders
1924 Citations (Scopus)

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer

Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C. & Alberts, S. R., 2004, In : Journal of Clinical Oncology. 22, 1, p. 23-30 8 p.

Research output: Contribution to journalArticle

irinotecan
oxaliplatin
Leucovorin
Fluorouracil
Colorectal Neoplasms
52 Citations (Scopus)

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: Simulations based on the 20,800 patient ACCENT data set

De Gramont, A., Hubbard, J. M., Shi, Q. D., O'Connell, M. J., Buyse, M., Benedetti, J., Bot, B., O'Callaghan, C., Yothers, G., Goldberg, R. M., Blanke, C. D., Benson, A., Deng, Q., Alberts, S. R., Andre, T., Wolmark, N., Grothey, A. F. & Sargent, D., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 460-465 6 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Disease-Free Survival
Recurrence
Survival
Therapeutics
16 Citations (Scopus)

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Lee, A. M., Shi, Q. D., Alberts, S. R., Sargent, D. J., Sinicrope, F. A., Berenberg, E. L., Grothey, A. F., Polite, B., Chan, E., Gill, S., Kahlenberg, M. S., Nair, S. G., Shields, A. F., Goldberg, R. M. & Diasio, R. B., 2016, In : Pharmacogenetics and Genomics. 26, 3, p. 133-137 5 p.

Research output: Contribution to journalArticle

Fluorouracil
Colonic Neoplasms
Drug Therapy
Poisons
Combination Drug Therapy
1 Citation (Scopus)

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Kommalapati, A., Tella, S. H., Goyal, G., Borad, M. J., Alberts, S. R., Roberts, L. R., Hubbard, J. M., Durgin, L., Cleary, S. & Mahipal, A., Jan 1 2018, (Accepted/In press) In : HPB.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Survival
Liver
Therapeutics
Insurance
36 Citations (Scopus)

Association of DNA mismatch repair and mutations in BRAF and KRAS with survival after recurrence in stage III colon cancers: A secondary analysis of 2 randomized clinical trials

Sinicrope, F. A., Shi, Q. D., Allegra, C. J., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Meyers, J. P., Pogue-Geile, K. L., Yothers, G., Sargent, D. J. & Alberts, S. R., 2017, In : JAMA oncology. 3, 4, p. 472-480 9 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Randomized Controlled Trials
Recurrence
Mutation
35 Citations (Scopus)
Colonic Neoplasms
Disease-Free Survival
Smoking
Recurrence
Neoplasms
32 Citations (Scopus)
3' Untranslated Regions
MicroRNAs
Colonic Neoplasms
Genotype
Clinical Trials
1773 Citations (Scopus)

Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200

Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A. & Benson, A. B., Apr 20 2007, In : Journal of Clinical Oncology. 25, 12, p. 1539-1544 6 p.

Research output: Contribution to journalArticle

oxaliplatin
Leucovorin
Fluorouracil
Colorectal Neoplasms
Survival
170 Citations (Scopus)

Borderline resectable pancreatic cancer: Need for standardization and methods for optimal clinical trial design

Katz, M. H. G., Marsh, R., Herman, J. M., Shi, Q. D., Collison, E., Venook, A. P., Kindler, H. L., Alberts, S. R., Philip, P., Lowy, A. M., Pisters, P. W. T., Posner, M. C., Berlin, J. D. & Ahmad, S. A., Aug 2013, In : Annals of Surgical Oncology. 20, 8, p. 2787-2795 9 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Pancreatectomy
Neoadjuvant Therapy
Clinical Trials
Blood Vessels
28 Citations (Scopus)

Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: Phase II results from the north central cancer treatment group (N044B)

Jatoi, A., Dakhil, S. R., Foster, N. R., Ma, C., Rowland, K. M., Moore, D. F., Jaslowski, A. J., Thomas, S. P., Hauge, M. D., Flynn, P. J., Stella, P. J. & Alberts, S. R., May 2008, In : Journal of Thoracic Oncology. 3, 5, p. 516-520 5 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Stomach Neoplasms
Neoplasms
Confidence Intervals
14 Citations (Scopus)

Building a protocol expressway: The case of Mayo Clinic Cancer Center

McJoynt, T. A., Hirzallah, M. A., Satele, D. V., Pitzen, J. H., Alberts, S. R. & Rajkumar, S. V., Aug 10 2009, In : Journal of Clinical Oncology. 27, 23, p. 3855-3860 6 p.

Research output: Contribution to journalArticle

Clinical Protocols
Neoplasms
Clinical Trials
Staff Development
National Cancer Institute (U.S.)
20 Citations (Scopus)

Cancers of the buccal cavity and pharynx in Circumpolar Inuit

Lanier, A. P. & Alberts, S. R., 1996, In : Acta Oncologica. 35, 5, p. 545-552 8 p.

Research output: Contribution to journalArticle

Tongue Neoplasms
Cheek
Mouth Neoplasms
Pharynx
Lip Neoplasms
39 Citations (Scopus)

Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial

Alberts, S. R., Fitch, T. R., Kim, G. P., Morlan, B. W., Dakhil, S. R., Gross, H. M. & Nair, S., Aug 2012, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 35, 4, p. 329-333 5 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Clinical Trials
Neoplasms
Therapeutics
Vascular Endothelial Growth Factor A
17 Citations (Scopus)

Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia

Alberts, S. R. & Blute, M. L., 2001, In : Urology. 57, 4 SUPPL. 1, p. 188-190 3 p.

Research output: Contribution to journalArticle

Prostatic Intraepithelial Neoplasia
Flutamide
Chemoprevention
Carcinoma
Adenocarcinoma
41 Citations (Scopus)

Chemotherapy for colorectal cancer liver metastases

Alberts, S. R. & Wagman, L. D., 2008, In : Oncologist. 13, 10, p. 1063-1073 11 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Colorectal Neoplasms
Neoplasm Metastasis
Drug Therapy
oxaliplatin
137 Citations (Scopus)

Chemotherapy permits resection of metastatic colorectal cancer: Experience from intergroup N9741

Delaunoit, T., Alberts, S. R., Sergent, D. J., Green, E., Goldberg, R. M., Krook, J., Fuchs, C., Ramanathan, R. K., Williamson, S. K., Morton, R. F. & Findlay, B. P., Mar 2005, In : Annals of Oncology. 16, 3, p. 425-429 5 p.

Research output: Contribution to journalArticle

oxaliplatin
Colorectal Neoplasms
Drug Therapy
irinotecan
Fluorouracil
50 Citations (Scopus)

Clinical predictors of severe cetuximab-induced rash: Observations from 933 patients enrolled in north central cancer treatment group study N0147

Jatoi, A., Green, E. M., Rowland, K. M., Sargent, D. J. & Alberts, S. R., Aug 2008, In : Oncology. 77, 2, p. 120-123 4 p.

Research output: Contribution to journalArticle

Exanthema
Neoplasms
Therapeutics
Odds Ratio
Confidence Intervals
27 Citations (Scopus)

Clustering of hepatocellular carcinoma in Alaska Native families

Alberts, S. R., Lanier, A. P., McMahon, B. J., Harpster, A., Bulkow, L. R., Heyward, W. L. & Murray, C., 1991, In : Genetic Epidemiology. 8, 2, p. 127-139 13 p.

Research output: Contribution to journalArticle

Cluster Analysis
Hepatocellular Carcinoma
Hepatitis B virus
Lymphocytes
Antigens
20 Citations (Scopus)

Colorectal cancer in Alaska native people, 2005-2009

Kelly, J. J., Alberts, S. R., Sacco, F. & Lanier, A. P., Sep 2012, In : Gastrointestinal Cancer Research. 5, 5, p. 149-154 6 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Incidence
Survival
Neoplasms
Alaska Natives

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

Levy, M. J., Gleeson, F. C., Topazian, M., Fujii-Lau, L. L., Enders, F. T., Larson, J. J., Mara, K., Abu Dayyeh, B. K., Alberts, S. R., Hallemeier, C., Iyer, P. G., Kendrick, M. L., Mauck, W. D., Pearson, R. K., Petersen, B. T., Rajan, E., Takahashi, N. M., Vege, S. S., Wang, K. K. N. & Chari, S. T., Mar 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 4, p. 728-738.e9

Research output: Contribution to journalArticle

Celiac Plexus
Sympathetic Ganglia
Survival
Pain
Quality of Life
79 Citations (Scopus)

Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer

Haddock, M., Miller, R. C., Nelson, H., Pemberton, J. H., Dozois, E., Alberts, S. R. & Gunderson, L. L., Jan 1 2011, In : International Journal of Radiation Oncology Biology Physics. 79, 1, p. 143-150 8 p.

Research output: Contribution to journalArticle

electron radiation
Combined Modality Therapy
electron irradiation
Colorectal Neoplasms
radiation therapy
8 Citations (Scopus)

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Alberts, S. R., Yu, T. M., Behrens, R. J., Renfro, L. A., Srivastava, G., Soori, G. S., Dakhil, S. R., Mowat, R. B., Kuebler, J. P., Kim, G. P., Mazurczak, M. A. & Hornberger, J., Nov 26 2014, In : PharmacoEconomics. 32, 12, p. 1231-1243 13 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Colonic Neoplasms
Economics
Costs and Cost Analysis
Recurrence
27 Citations (Scopus)

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

Fluorouracil
Pharmacokinetics
Neoplasms
Dihydrouracil Dehydrogenase (NADP)
eniluracil
61 Citations (Scopus)

Comparison of estrogen receptor determinations by a biochemical ligand- binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

Alberts, S. R., Ingle, J. N., Roche, P. R., Cha, S. S., Wold, L. E., Farr, G. H., Krook, J. E. & Wieand, H. S., Aug 15 1996, In : Cancer. 78, 4, p. 764-772 9 p.

Research output: Contribution to journalArticle

Charcoal
Estrogen Receptors
Dextrans
Lymph Nodes
Monoclonal Antibodies
30 Citations (Scopus)

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147

Huang, J., Nair, S. G., Mahoney, M. R., Nelson, G. D., Shields, A. F., Chan, E., Goldberg, R. M., Gill, S., Kahlenberg, M. S., Quesenberry, J. T., Thibodeau, S. N., Smyrk, T. C., Grothey, A. F., Sinicrope, F. A., Webb, T. A., Farr, G. H., Pockaj, B. A., Berenberg, J. L., Mooney, M., Sargent, D. J. & 1 others, Alberts, S. R., 2014, In : Clinical Colorectal Cancer. 13, 2, p. 100-109 10 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Disease-Free Survival
Neoplasms
irinotecan
Therapeutics
1 Citation (Scopus)
Dioxins
Environmental Exposure
Multiple Myeloma
Incidence
Neoplasms
30 Citations (Scopus)

CPT-11 for bile-duct and gallbladder carcinoma: A phase II North Central Cancer Treatment Group (NCCTG) study

Alberts, S. R., Fishkin, P. A., Burgart, L. J., Cera, P. J., Mahoney, M. R., Morton, R. F., Johnson, P. A., Nair, S. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 107-114 8 p.

Research output: Contribution to journalArticle

irinotecan
Bile Ducts
Gallbladder
Carcinoma
Neoplasms